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**Introduction:** Performing a bronchoscopy is commonly used for investigating patients with possible pulmonary TB when spontaneous sputum is smear negative. Currently there is no evidence that BAL is superior to BW in sputum smear negative pulmonary TB. General consensus varies between clinicians.

**Aim:** To determine if performing a BAL yields a higher diagnostic rate compared to BW alone in pulmonary TB.

**Method:** In a prospective study of subjects (n = 50) with possible active pulmonary tuberculosis, the diagnostic yield of BAL was compared to BW. Subjects either produced no sputum or had (acid fast) smear negative sputum. BAL and BW were performed on all the patients. The order of BAL and BW was randomized. Our primary outcome was the percentage of culture positive results in BW and BAL. The secondary outcome was the percentage of smear positive results in BW and BAL.

**Results:** Interim analysis of the data (n = 20) demonstrated a mean (SD) age of 38 (19.6) years, with subjects mainly from Vietnam (25%), India (25%) and Burma (20%). Five subjects (25%) had culture positive results: 4 in both BW and BAL. In one subject, while the BW was culture negative for *Mycobacterium tuberculosis* (MTB), the BAL was culture positive, providing an additional confirmatory diagnosis. The agreement between BW and BAL was excellent (0.86 Cohen\'s Kappa). The yield of positive smear results was low (1 case) and noted in both the BW and BAL.

**Conclusion:** In subjects who either cannot expectorate sputum or have a smear negative sputum requiring bronchoscopy, adding a BAL to a standard BW maybe be clinically indicated given the public health issue and importance of making a firm diagnosis.
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**Introduction:** Lymph node tuberculosis (LNTB) is the most common form of extra‐pulmonary TB, accounting for approximately 15% of all TB cases in Australia. However, data on LNTB are sparse.

**Aim:** To describe clinical and epidemiological characteristics of peripheral LNTB in comparison to pulmonary TB (PTB).

**Methods:** We conducted a case‐control study comparing patients with peripheral LNTB with randomly selected patients with PTB diagnosed at a Sydney TB clinic, between January 2000 and December 2012. Epidemiological and medical data were extracted from the electronic hospital database and medical records. The data were examined for associations between LNTB and age, sex, ethnicity, BCG vaccination status and comorbidities (HIV, diabetes and chronic kidney disease) in comparison to PTB, using logistic regression in a univariate and multivariate analysis.

**Results:** There were 213 cases with LNTB and 426 randomly selected controls with PTB. Among patients with LNTB, 74% were female and the mean age (SD) was 42 (16) years. Among patients with PTB, 43% were female and the mean age was 44 (22) years. Females, 45--64 year olds, and Southern Asians had an increased risk for LNTB (Odds ratio (OR) 2.98, 95% CI 1.99 to 4.48; OR 2.37, 95% CI 1.22 to 4.60 and OR 3.52, 95% CI 1.34 to 9.24 respectively). Patients with diabetes were at a higher risk of PTB (OR 0.42, 95% CI 0.20 to 0.88 for LNTB).

**Conclusion:** This is the first Australian study comparing the epidemiology of LNTB to that of PTB. An increased risk for LNTB was found among females, people aged 45--64 years and people born in Southern Asia. An increased risk for PTB was found among patients with diabetes.
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**Introduction:** A major strength of the Mongolian National Tuberculosis Program (NTP) is a dedicated network of 300 volunteers, coordinated by the Mongolian Anti‐Tuberculosis Association (MATA), who provide decentralized tuberculosis (TB) treatment under direct supervision.

**Aim:** To evaluate the treatment success of two community‐supported directly observed therapy (cDOT) strategies (home‐DOT and lunch‐DOT) in comparison to traditional clinic‐DOT in Ulaanbaatar, Mongolia. With 'home‐DOT' volunteers delivered treatment at home; with 'lunch‐DOT' volunteers provided treatment after patients had a free meal at a cafe contracted by MATA.

**Methods:** We analysed NTP data of all sputum smear‐positive patients commenced on TB treatment in 9 districts (aimags) of Ulaanbaatar (2010--2011) to assess treatment outcome with different DOT strategies. Treatment success included 'cure' and 'treatment completed' based on WHO definitions. Multivariate logistic regression analysis adjusted for age, sex, occupation/socioeconomic status and patient category (new, default, failure, relapse, transfer in).

**Results:** Of 2,315 sputum smear‐positive TB patients 1835 (79.3%) received clinic‐DOT, 354 (15.3%) home‐DOT and 126 (5.4%) lunch‐DOT. Patients on cDOT were more likely to be unemployed with 47% of patients on home‐DOT and 52% of patients on lunch‐DOT being unemployed compared to 41% on clinic‐DOT. The median age was 32 (interquartile range, IQR, 19) years in patients on clinic‐DOT, 29 (IQR 22) years in patients on home‐DOT and 36 (IQR 25) in patients on lunch‐DOT. The proportion of males was 58%, 52% and 53% among clinic‐DOT, home‐DOT and lunch‐DOT respectively. In multivariate analysis home‐DOT and lunch‐DOT had a significantly higher treatment success than clinic‐DOT (93%, OR 3.2; 95% CI 2.1 to 4.9 for home‐DOT and 98%, OR 16.0; 95% 3.9 to 65.4 for lunch‐DOT compared to 78% for clinic‐DOT).

**Conclusion:** Higher treatment success was achieved with cDOT, especially lunch‐DOT, than with traditional clinic‐DOT. Detailed feasibility and cost‐benefit analysis seems warranted also assessing its value in managing MDR‐TB.

TP 205. THE BACTERIOLOGY OF PLEURAL INFECTION IN WESTERN AUSTRALIA {#resp12263_13-sec-0004}
==================================================================

BRIMS F^1,2,5^, ROSENSTENGAL A^1^, FRANKE A^1^, YOGENDRAN A^1^, LEE F^1^, READ C^1,5^, HART J^3,4^, KAY I^3,4^, WATERER G^2,4^, LEE Y^1,2,5^

^*1*^ *Sir Chalres Gairdner Hospital, Perth, WA,* ^*2*^ *University of Western Australia, WA,* ^*3*^ *PathWest Laboratory Medicine,* ^*4*^ *Royal Perth Hospital, WA,* ^*5*^ *Lung Institute of Western Australia*

**Introduction:** There is frequently marked geographical variation in the bacteriology of pleural cultures and differences in nosocomial and community acquired bacteriology. We undertook an analysis of all pleural fluid cultures from the public hospitals in the Perth metro area, Western Australia.

**Method:** Data were extracted from the PathWest microbiology laboratory database on any episodes coded to have a positive pleural fluid culture between 2006 to 2011. Casenote and stored electronic health record data were reviewed for demographics, length of stay, survival, biochemistry and systemic inflammatory markers.

**Results:** 713 cases with 968 positive cultures were available for analysis. Median age was 63.7 years, 502/713 (70.4%) were male and 418/713 (58.6%) right sided. 153 different organisms were isolated; the main isolates are summarized: 11.9% Staphylococcus aureus, 9.49% Streptococcus viridans, 9.11% other aerobes (mixed), 7.12% S. angiosus group, 6.24% gram‐negative rods, 5.12% pseudomonas aeruginosa, 4.12% E. coli, 3.62% Klebsiella spp., 3.37% MRSA. Analysis also revealed organisms never before reported in association with pleural infection (e.g. Klebsiella oxytoca). Median (IQR) pleural fluid pH was 7.30 (6.69--7.59), glucose 2.7 mmol/L (0.5--5.8), LDH 800 iu/L (248--3188), white cell count 12.7 × 10^9^ (8.98--17.4), c‐reactive protein 172 mg/L (74--280). Median survival following infection was 68.0 days (20.0--322.0). 151 cases had community‐acquired infection (CAI) and 298 hospital‐acquired infection (HAI). Compared to HAI, CAI had more isolates of S. angiosus and S. viridans groups (both p \< 0.05) and HAI had more MRSA, Enterococci, Klebsiella spp. (all p \< 0.05). One‐year survival was greater with CAI (OR 1.68, 95% CI 1.14 to 2.55; p = 0.014).

**Conclusions:** Elucidation of local bacteriology for pleural infection may reveal unique isolates and patterns. In this population, pleural infection is associated with a poor prognosis. Important differences exist in the bacteriology and outcomes of community and hospital acquired infection.
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**Introduction:** Pulmonary aspergillosis is a significant cause of morbidity and mortality in immunocompromised patients. Accurate diagnosis and specific treatment improves outcomes. Galactomannan (GM) is a major constituent of Aspergillus cell walls released during hyphal growth, indicating active replication. Bronchoalveolar lavage (BAL) GM may increase diagnostic accuracy but the optimal optical density (OD) cut‐off has not been determined, and our earlier data suggests it may be different in sub‐groups of immunocompromised patients.

**Aims:** Evaluate utility and determine optimal OD of BAL GM in diagnosis of pulmonary aspergillosis in sub‐groups of immunocompromised patients.

**Method:** Immunocompromised patients requiring bronchoscopy for surveillance or clinical indications over a three year period. Patients were grouped into the following categories for analysis: human immunodeficiency virus infection, thoracic transplant recipients, other solid‐organ transplant, haematological malignancy, bone marrow transplantation recipient etc. BAL specimens were analysed for GM using enzyme‐linked immunosorbent assay. Optimal OD was calculated using receiver operating characteristic analysis compared with the current gold standard -- direct microscopy and fungal cultures.

**Results:** 233 bronchoscopies were performed. Fungal elements were negative in all but 2 patients. There were 26 positive fungal cultures positive for Aspergillus and this was used as the gold standard in comparison with GM. As an overall group, the optimal OD was 0.6. Subsets of immunocompromised patients were also assessed. The thoracic transplant recipients group and allogenic bone marrow transplant recipients/acute leukaemias group both had an optimal OD of 0.5. Oncological malignancy and lymphoma patients had a higher optimal OD of 0.9.

**Conclusions:** BAL GM increases early detection of pulmonary aspergillosis in immunocompromised patients. The optimal OD cut off differs between subgroups. The reason for immunosuppression should be considered when interpreting GM results.
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**Aim:** Acute lower respiratory infection (ALRI) is the leading cause of childhood mortality worldwide. The most common cause of viral respiratory infections is human rhinovirus (HRV). Despite high ALRI‐associated mortality, the role of viruses in childhood ALRI in sub‐Saharan Africa is poorly understood. We aimed to describe the viral aetiology of ALRI in hospitalized children in rural Mozambique.

**Method:** Nasopharyngeal aspirates were collected from 180 children \<10 years of age admitted to Manhiça District Hospital with a fever and (WHO defined) clinical pneumonia as part of a study characterizing children with respiratory distress. HIV and malaria testing was offered and patients underwent chest X‐ray and extensive clinical and laboratorial screening. Respiratory viruses (adenovirus, respiratory syncytial virus, parainfluenza virus, metapnuemovirus, bocavirus, enterovirus, influenza and coronavirus) were identified using two independent multiplex RT‐PCR assays with primers specific for each virus and virus type. HRV species and genotypes were identified using a molecular method involving RNA extraction, semi‐nested PCR amplification, sequencing and phylogenetic tree analysis.

**Results:** A total of 180 children (49.4% male) with a mean age of 20.8 months were recruited. Twenty‐five (13.9%) children were HIV‐positive. At least one respiratory virus was identified in 150 (83.3%) children while co‐infection with two, three and four viruses were identified in 47 (26.1%), 11 (6.1%) and 3 (1.7%) children respectively. HRV was the most common (51.7%) virus identified, followed by adenovirus (15.6%), respiratory syncytial virus (15.6%), parainfluenza virus (10%), metapnuemovirus (8.3%), bocavirus (8.3%), enterovirus (6.1%), influenza (5.0%) and coronavirus (1.7%). Of the 76 HRV genotyped specimens, 41 (53.9%) were HRV‐A, 28 (36.8%) were HRV‐C and 7 (9.2%) were HRV‐B. HRV was associated with HIV‐infection (p = 0.028) and respiratory symptoms including wheezing (p = 0.005).

**Conclusion:** HRV is likely to contribute to ALRI in hospitalized children in Mozambique. HIV has a strong impact on viral infections.

**Key words:** human rhinovirus, acute lower respiratory infections.
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**Aim:** Influenza is responsible for substantial morbidity and mortality. Guidelines suggest antipyretic use; however fever may have a protective effect and antipyretics increase mortality in animal influenza models. We investigated the effects of paracetamol on viral shedding and clinical symptoms in adults with influenza.

**Methods:** In a randomized, double blind, placebo‐controlled trial 80 participants with an influenza‐like illness received paracetamol or placebo for five days. Temperature was recorded for five days and symptom scores were recorded until day 14. Pernasal swabs were taken for quantitative viral load RT‐PCR analysis at baseline, day one, two, and five. The primary outcome variable was area under the curve quantitative PCR viral load over days zero to five.

**Results:** 80 subjects were enrolled with none lost to follow up. Twenty two participants in the control group and 24 in the paracetamol group were PCR positive for influenza. There was no significant difference between the groups in the primary outcome measure. The AUC for quantitative PCR Log 10 viral load over days 0 to 5 (control group minus paracetamol group) was −0.24, 95% CI −0.78 to 0.29 (P = 0.36). There was no significant difference between the groups in the secondary virological or clinical outcomes. Regular paracetamol had no significant effect on temperature or symptoms compared to the placebo group.

**Conclusion:** Regular paracetamol had no significant effect on temperature, symptoms, or viral shedding in patients with influenza. There was a lower than expected positive PCR rate hence the study may have been underpowered to detect a difference. The lack of efficacy of paracetamol as an antipyretic meant we were not able to sufficiently suppress fever. Further work is required in order to define the role of fever in influenza infection. Until then the regular administration of paracetamol as an antipyretic in influenza cannot be recommended.

TP 209. A COMPARATIVE STUDY OF ANTIBIOTIC PRESCRIPTION FOR COMMUNITY ACQUIRED PNEUMONIA IN RESPIRATORY UNITS WITH AND WITHOUT AN ANTIMICROBIAL STEWARDSHIP PROGRAMME {#resp12263_13-sec-0008}
====================================================================================================================================================================

AIYAPPAN V^1^, NYFORT‐HANSEN K^2^, MANGIRA D^3^, LENGHAUS D^3^, MORTON S^3^

^*1*^ *Flinders Medical Centre and Flinders University,* ^*2*^ *Repatriation General Hospital,* ^*3*^ *Flinders Medical Centre*

**Introduction:** Antibiotic restriction policies are in place in a large number of hospitals, to decrease the emergence of multi‐resistant organisms and to prevent side‐effects. However, the need and effectiveness of these restrictions in speciality units have not been assessed previously.

**Aim:** To compare antibiotic prescribing for patients admitted with community acquired pneumonia(CAP) at respiratory units at two teaching campuses within the same region in Adelaide; Flinders Medical Centre (FMC) (with administrative control of antibiotic prescribing), and Repatriation General Hospital (RGH) (with no administrative control of antibiotic prescribing).

**Method:** Multicentre retrospective observational study.

**Results:** A total of 37 patients were admitted with diagnosis of CAP (25 at FMC and 12 at RGH) of which FMC had 48% females and RGH had 58 % females. The majority of patients in RGH had a Pneumonia Severity Index (PSI) score of IV (75%) or V (17%) while at FMC 24% of patients had PSI of III, 20% had PSI of IV and 24% had PSI of V. CAP guidelines were followed in 60% of patients at FMC compared to 75% at RGH (two‐tailed Fisher test p = 1.00).One patient had an antibiotic associated adverse event at FMC compared to none at RGH. There was one death at each of the hospitals. The average length of stay was not significantly different (7 days at FMC and 8 days at RGH).

**Conclusion:** The adherence of respiratory units to CAP guidelines in this study is high, irrespective of administrative antibiotic restriction. The presence of restrictions did not increase adherence to the guideline and suggest that well produced guidelines, with adequate education of staff may make prescribing limitations unnecessary, especially in a speciality unit dealing with infections involving their area of expertise.

TP 210. PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR γ GENE EXPRESSION IN THE AIRWAYS OF NON CYSTIC FIBROSIS BRONCHIECTASIS SUBJECTS IS INVERSELY CORRELATED WITH TOTAL PSEUDOMONAS AERUGINOSA BACTERIAL LOAD BUT POSITIVELY CORRELATED WITH ABSOLUTE MACROPHAGE LEVELS {#resp12263_13-sec-0009}
=====================================================================================================================================================================================================================================================================

BURR L^1,2^, ROGERS G^1^, CHEN A^1^, SERISIER D^1,2^

^*1*^ *Mater Research,* ^*2*^ *Mater Health Services, Brisbane QLD 4102*

**Background and Aim:** The aim for this experiment is to assess the level of expression of *pparγ* in non‐cystic fibrosis bronchiectasis subjects as compared to healthy controls. *Pparγ* is an anti‐inflammatory nuclear receptor gene expressed widely in the lung. Low levels of airway PPARγ is associated with an increased likelihood of *P. aeruginosa* positivity in the cystic fibrosis lung. It is postulated that the *P. aeruginosa* quorum sensing molecule 3‐oxo‐C12‐homoserine lactone antagonizes *pparγ*, inhibiting its transcription.

**Methods:** Forty one non‐CF bronchiectasis subjects and 20 healthy controls underwent fibreoptic bronchoscopy sampling for the collection of lavage fluid. Messenger RNA was extracted from the samples and reverse transcribed to total cDNA using random hexamer primers. Expression of the gene encoding PPARγ was measured using real time PCR, with levels normalized to beta actin gene expression.

**Results:**  *Pparγ* expression was lower in non‐CF bronchiectasis subjects compared with controls (p = 0.0001), and lower in those patients who were PCR positive for *P. aeruginosa* (p = 0.012). There was an inverse correlation with *P. aeruginosa* load (r~s~ −0.531, p = 0.002), which was not seen with either total bacterial load (r~s~ 0.239 p = 0.194) or *Haemophilus influenzae* load (r~s~ 0.297, p = 0.325). *Pparγ* expression was positively correlated with absolute macrophage count (r~s~ 0.377, p = 0.044), consistent with the inverse correlation of *P. aeruginosa* with total macrophage level (r~s~ −0.403 p = 0.025).

**Conclusion:**  *Pparγ* expression in the airways of non‐CF bronchiectasis subjects is significantly reduced compared to healthy individuals. This reduction is correlated with lower levels of macrophages (a cell type where the PPARγ gene is highly expressed) and increased levels of *P. aeruginosa*. Whether the reduction in *pparγ* is purely a reflection of low macrophage levels or a due to its interaction with *P. aeruginosa* warrants further study.
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**Introduction:** Neutrophils are important in controlling infections, in particular respiratory virus infections. During these times there are increases in neutrophil numbers and products. Neutrophillic inflammation is associated with more severe asthma symptoms and corticosteroid insensitivity. Their role in viral‐induced asthma exacerbations or if neutrophils directly respond to respiratory viruses is not fully understood.

**Aim:** To investigate if neutrophils are activated by viral surrogates (TLR agonists) and different infectious respiratory viruses. To identify whether asthmatic and non‐asthmatic neutrophils respond differently to viral surrogates.

**Method:** Peripheral blood samples were collected from mild asthmatic (n = 9--11) and non‐asthmatic individuals (n = 13--18). Neutrophils were stimulated with LPS (1 μg/ml), FMLP (100 nM), imiquimod (3 μg/ml), R848 (1.5 μg/ml), poly I:C (10 μg/ml), rhinovirus (RV)‐16 (MOI 1), respiratory syncytial virus (RSV) (MOI 1) or influenza virus (MOI 1). Cell free supernatant was collected after 1 h for measurement of neutrophil elastase (NE) and matrix metalloproteinase (MMP)‐9 release or after 24 h for interleukin (IL)‐8 release.

**Results:** LPS, FMLP, imiquimod and R848 stimulated the release of IL‐8, NE and MMP‐9. However, poly I:C induced only IL‐8 release. There was no difference between asthmatic and non‐asthmatic neutrophil responses, except for R848 in which neutrophils from asthmatic patients released significantly more IL‐8 than control patients (p \< 0.01). RSV caused the release of IL‐8 and NE but not MMP‐9 in neutrophils. However, RV‐16 and influenza virus did not cause the release of any of the three mediators measured.

**Conclusion:** Neutrophils can detect and respond to viral surrogates by releasing IL‐8, NE and MMP‐9. However, neutrophils do not mount a response to RV‐16 or influenza virus but they do detect and respond to RSV. Some respiratory viruses may not induce neutrophillic inflammation directly but this form of inflammation may be a result of neutrophil interactions with adjacent infected cells.
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**Aim:** To evaluate and characterize the *in vitro* cytokine effects of bacterial pleural pathogens on mesothelial cells.

**Methods:** The benign MeT‐5A pleural mesothelial cell line was treated with live or heat‐killed *Staphylococcus aureus* (reference strains and clinical isolates) or Streptococcal species for up to 24 hr. Interleukin (IL)‐6, IL‐8 and vascular endothelial growth factor (VEGF) release was determined by enzyme‐linked immunosorbent assay. *S. aureus‐*conditioned media was subject to protein fractionation based on molecular weight using Amicon® Ultra‐4 Centrifugal Filter Units (Millipore).

**Results:** Live, but not heat‐killed, *S. aureus* reference strains induced IL‐6, IL‐8 and VEGF release from MeT‐5A cells in a time‐ and dose‐dependent manner. This result was verified using *S. aureus* clinical isolates obtained from blood cultures. Conversely, *Streptococcus pneumoniae* or *S. milleri* group bacteria did not induce cytokine release from MeT‐5A cells. *S. aureus*‐induced IL‐6 and VEGF, but not IL‐8, release was mediated via a bacterial exoproduct, which was resistant to heat, deoxyribonuclease and ribonuclease treatment. Selective ultra‐filtration of *S. aureus* conditioned media revealed that the cytokine‐inducing activity was retained in concentrates containing exoproducts \<30 kDa in size.

**Conclusions:** Of the most common bacterial empyema pathogens only *S. aureus* induced the release of the cytokines tested from pleural mesothelial cells *in vitro*. The results using heat‐killed bacteria and conditioned media indicate the causative factor is an actively secreted product from *S. aureus.*
